Analysis of DNAH11 gene variants and clinical characteristics of a Chinese pedigree affected with Primary ciliary dyskinesia.
10.3760/cma.j.cn511374-20250724-00450
- Author:
Xiaodong WANG
1
,
2
;
Ying XU
;
Lan JIANG
;
Quyang YANG
;
Liyang LIU
;
Meng LI
;
Qingchuan DUAN
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Henan Provincial Engineering Research Center for Early Diagnosis and Precise Treatment of Sleep and Breathing Disorders, Zhengzhou, Henan 450018, China. xuy1218@
2. com.
- Publication Type:English Abstract
- MeSH:
Humans;
Pedigree;
Female;
Axonemal Dyneins/genetics*;
Male;
Child;
Asian People/genetics*;
Kartagener Syndrome/genetics*;
Mutation;
Phenotype;
China;
Adult;
East Asian People
- From:
Chinese Journal of Medical Genetics
2025;42(11):1347-1353
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the genetic etiology of a Chinese pedigree affected with Primary ciliary dyskinesia (PCD).
METHODS:A child who presented at the ENT Department of Zhengzhou University Children's Hospital in March 2024 due to secretory otitis media, chronic sinusitis, adenoid hypertrophy, dextrocardia, and bronchiectasis was selected as study subject. Relevant clinical data were collected. Peripheral blood samples from the child and her family members were collected. Following DNA extraction, whole exome sequencing was carried out. Candidate variants were validated by Sanger sequencing, and the correlation between the variants and phenotype was analyzed. This study was approved by the Medical Ethics Committee of the Hospital (Ethics No.: 2024-K-135).
RESULTS:The child and her elder siblings exhibited similar clinical manifestations including recurrent cough, secretory otitis media, chronic sinusitis, tracheobronchitis, and pneumonia. The child also presented with bronchiectasis and visceral situs inversus. Genetic testing results indicated that the child and her elder siblings had all harbored compound heterozygous variants of the DNAH11 gene, namely c.3000 1G>A and c.5775C>G (p.Tyr1925*), which were respectively inherited from their phenotypically normal parents. Both variants can affect mRNA splicing and protein translation integrity. Based on the guidelines from the American College of Medical Genetics and Genomics, both variants were classified as likely pathogenic. It was predicted that they may jointly lead to a functional defect in axonemal dynein, resulting in the phenotype of PCD, conforming to an autosomal recessive inheritance.
CONCLUSION:The compound heterozygous variants c.3000 1G>A and c.5775C>G (p.Tyr1925*) of the DNAH11 gene probably underlay the pathogenesis of PCD in this pedigree. The same variant in different individuals may lead to different clinical phenotypes, which has reflected significant heterogeneity in genetic background and clinical phenotype. Above findings have enriched the mutational spectrum of PCD gene and have important implications for the accurate diagnosis, treatment, prognosis, and genetic counseling.
